spacer
home > pmps > summer 2002 > containment by airflow for highly potent materials
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Containment by Airflow for Highly Potent Materials

This article was prepared in response to a common question posed by manufacturing facilities, 'Can we process highly potent materials (above 50 microgram/m3) using containment by airflow devices, such as downflow booths?' The simple answer to this is 'yes', but it is not a recommended best practice for a number of reasons. This question is normally asked because the manufacturing facility wants to avoid the use of isolation technology due to:

Perceived high capital cost
Restrictions placed with respect to the operator's ability
to interface with the target operation
Space requirements

This article discusses the reasons why using containment by airflow devices is not best practice for high potency products and puts forward the case for closed processing of these materials using isolation technology.

Containment By Airflow

Containment by airflow systems provide operator protection by moving air at high velocity across the area where the required material is being handled. The premise here is that any airborne contamination is captured by the airflow and eventually captured in filter media. By their nature containment by airflow devices are open systems - that is, there is no physical barrier between the hazardous material and the operator.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Hari Floura, President of Operations for Applied Containment Engineering Inc. Hari Floura is the President of Operations for Applied Containment Engineering Inc. Since obtaining his degree in Industrial Design Engineering in 1988, Hari has worked exclusively in the field of containment technology within the pharmaceutical industry.
Prior to the inauguration of Applied Containment Engineering Inc. in July 2001, Hari held positions with Parsons Inc, Kvaerner Process, Total Process Containment Ltd, Process Containment Technology Ltd and Extract Technology Ltd. During this time he has been responsible for R&D, conceptual/detail design, project management, assembly, installation and validation for a number of successful containment projects.
Hari has also provided consultancy to many major pharmaceutical companies with respect to their containment guidelines, and facility and containment system designs. He is also a member and regular presenter at the International Society of Pharmaceutical Engineers, and sits on the Standardized Measurement of Equipment Particulate Airborne Concentration (SMEPAC) Committee.

spacer
Hari Floura
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Breakthrough in the global battle against polio: AJ Vaccines granted WHO prequalification for new polio vaccine

Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with more cases registered in 2019 than 2018. Looking ahead, AJ Vaccinesí dose sparing technology provides a significant opportunity to expand supply, with the potential to deliver up to 100 million doses over the five-year period 2020-2024 to help meet the currently unmet global demand for inactivated polio vaccines.
More info >>

White Papers

Tabletability, Compactability, and Compressibilty: Whatís the Difference?

Natoli Engineering Company, Inc.

To patients and consumers, tablets are a simple and convenient dosage form. But the science behind compressing a block of particles or granules into a single tablet can be complicated. Thatís where common compression studies can help. This article explains how to develop tabletability, compactibility, and compressibility profiles.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement